Independent Capital
1925 Century Park E, Ste 1700, Los Angeles, CA, 90067, United States
Overview
As an independent full-service financial consulting and management firm, we are dedicated to helping our clients build wealth and preserve their hard-earned assets. Staffed by a team of experts with various financial disciplines, ICM offers a wide range of well-known products and services as it effectively guides clients through even the most complex financial situations. We recommend only those products and services that can be tailored to suit our clients' unique needs.
- Total investments
- 3
- Lead investments
- 1
- Investments · 12mo
- 1
- Active investors
- 0
Investment portfolio
- Autoimmunity BioSolutions
Participated · Seed · May 2026
Autoimmunity BioSolutions is developing a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7R (sIL7R), a driver of poor therapeutic response in autoimmune disease. The therapy targets a genetically defined subpopulation marked by a highly prevalent SNP estimated in roughly 50% of the population that increases sIL7R expression. ABS is focused on indications including rheumatoid arthritis, lupus nephritis, and type 1 diabetes where elevated sIL7R has been associated with greater severity, progression, and reduced response to standard treatments. The company plans near-term work to complete animal model studies and patient bio-sample analyses in rheumatoid arthritis. ABS has raised $3.1 million in total seed capital following the $1M seed extension and is headquartered in Houston. The company positions its approach as differentiated from immunosuppressive standards of care and aims to enhance response in refractory patient populations with elevated sIL7R.
- Kiwi
Led · Series A · May 2023
Founded in 2020 by Dominican Republic natives Mariano Sanz and Alexander Schachter, Kiwi offers an AI-driven mobile platform that provides small-dollar lines of credit to U.S. Latinos who lack traditional credit histories. The service has already reached more than 100,000 consumers and is designed to help users build or repair their credit profiles while accessing transparent, fairly priced capital. Kiwi follows a playbook proven in emerging markets: start with credit, then layer on savings, spending, and additional financial products to drive long-term economic mobility. The company targets the nearly 20 % of the U.S. population that is Latino, a segment contributing over $4 trillion annually to the economy yet remains underserved by mainstream financial institutions. Advanced AI underwriting and alternative data power Kiwi’s approvals, while the mobile experience simplifies repayment and credit-building for customers. With new institutional backing, the team plans to enter more states, roll out new product lines, and scale its platform to millions of users. Earlier in 2023, Kiwi raised an $8 million Series A to support these growth ambitions.
Team
No current team members are available.